Lymphoma is a cancer of the lymph nodes which are organs in which immune cells, particularly the antibody producing B cells, proliferate and differentiate before circulating in the blood and tissues to fight infection. B cell lymphoid cancers – ‘B cell lymphoma’ arise as a consequence of the occurrence of gene mutations in B cells. By affecting the functions of key B cell genes, these mutations drive the malignant transformation of the affected B cells which then begin to divide abnormally eventually destroying normal lymph node organization and function. The lymph node is divided into distinct micro-anatomical compartments or zones which are called (from the inner to outer most compartment – germinal centre, mantle zone, and marginal zone)...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
International audienceIntroductionLes techniques de Next generation sequencing (NGS) ont permis d’id...
Les lymphomes sont les 5èmes cancers les plus fréquents en France avec 22 000 cas diagnostiqués chaq...
Lymphoma is a cancer of the lymph nodes which are organs in which immune cells, particularly the ant...
Le lymphome est un cancer des ganglions lymphatiques, lieu de prolifération et différenciation des c...
Background: The frequency of the most observed cancer, Non Hodgkin Lymphoma (NHL), is further rising...
Le lymphome à cellules du manteau (LCM) est une pathologie rare qui présente une grande diversité de...
Mantle cell lymphoma (MCL) is a clinically aggressive disease for which molecular profiling-based pr...
Splenic marginal zone lymphoma (SMZL) and chronic lymphocytic leukaemia (CLL) are B cell malignancie...
Lymphomas are the 5th most common cancer in France with approximately 22,000 new cases diagnosed eac...
Next-generation sequencing (NGS) has detailed the genomic characterization of diffuse large B-cell l...
Le cancer est une maladie génétique des cellules somatiques caractérisée par l'accumulation d'anomal...
To identify recurrent genomic changes in mantle cell lymphoma (MCL), we used high-resolution compara...
L’outil génomique a considérablement modifié notre connaissance des hémopathies malignes, que ce soi...
Non-Hodgkin lymphoma (NHL) is the 13th most common type of cancer worldwide in 2020 and consists mai...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
International audienceIntroductionLes techniques de Next generation sequencing (NGS) ont permis d’id...
Les lymphomes sont les 5èmes cancers les plus fréquents en France avec 22 000 cas diagnostiqués chaq...
Lymphoma is a cancer of the lymph nodes which are organs in which immune cells, particularly the ant...
Le lymphome est un cancer des ganglions lymphatiques, lieu de prolifération et différenciation des c...
Background: The frequency of the most observed cancer, Non Hodgkin Lymphoma (NHL), is further rising...
Le lymphome à cellules du manteau (LCM) est une pathologie rare qui présente une grande diversité de...
Mantle cell lymphoma (MCL) is a clinically aggressive disease for which molecular profiling-based pr...
Splenic marginal zone lymphoma (SMZL) and chronic lymphocytic leukaemia (CLL) are B cell malignancie...
Lymphomas are the 5th most common cancer in France with approximately 22,000 new cases diagnosed eac...
Next-generation sequencing (NGS) has detailed the genomic characterization of diffuse large B-cell l...
Le cancer est une maladie génétique des cellules somatiques caractérisée par l'accumulation d'anomal...
To identify recurrent genomic changes in mantle cell lymphoma (MCL), we used high-resolution compara...
L’outil génomique a considérablement modifié notre connaissance des hémopathies malignes, que ce soi...
Non-Hodgkin lymphoma (NHL) is the 13th most common type of cancer worldwide in 2020 and consists mai...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
International audienceIntroductionLes techniques de Next generation sequencing (NGS) ont permis d’id...
Les lymphomes sont les 5èmes cancers les plus fréquents en France avec 22 000 cas diagnostiqués chaq...